Jeffrey R. Jasper

Jeffrey R. Jasper, Ph.D. graduated with a degree in chemistry in 1984. He earned his Ph.D. in pharmacology at UCSD’s School of Medicine and completed his postdoctoral training at Stanford. Jasper is Vice President of Preclinical Sciences at Revolution Medicines, Inc. and has more than 20 years of experience in the pharmaceutical industry, including Merck & Co., Roche, and Theravance. At Theravance - and in collaboration with GlaxoSmithKline- he assisted in the development of the medicine Breo Ellipta, for the treatment of pulmonary diseases. Jasper is co-founder of Altos Therapeutics, devoted to developing pharmaceuticals for gastrointestinal disorders. Jasper has served for more than 18 years on the Editorial Board for the American Journal of Physiology-Cell Physiology and has published 50 scientific articles in peer-reviewed journals. He served as past chair of the Biotechnology Industry Advisory Council at Cal Poly and frequently shares his expertise with students as a guest lecturer.